Abstracts

Gut Microbiome Dysbiosis and Lower Abundance of Butyrate Producing Bacteria in Neurologic PASC

Background: Neurologic post-acute sequelae of COVID-19 (PASC) affects a growing population of individuals, with symptoms including myalgic encephalomyelitis chronic fatigue syndrome (ME-CFS), cognitive dysfunction, dysautonomia, and neuropathy. Gut microbiome dysbiosis has been reported in the early convalescent period after SARS-COV-2 infection (10 years), metabolic dysfunction persists despite recovery of relative abundance of bacterial species. To…

Neurite Orientation Dispersion and Density Imaging in People With HIV on Stable Treatment

Background: Neurite Orientation Dispersion and Density Imaging (NODDI) is a multi-compartmental diffusion MRI technique that characterizes brain microstructures by quantifying the packing density of axons or dendrites (neurite density index, NDI), the orientational coherence of neurites (orientation dispersion index, ODI) and the free water fraction (isotropic compartment, ISO). This preliminary study compares NODDI metrics cross-sectionally…

Predictors of CD4/CD8 T-Cell Inversion After 96 Weeks of ART Initiated During Acute HIV

Background: >50% of people with HIV (PWH) do not achieve CD4/CD8 T-cell ratio normalization (ratio>1.0) on antiretroviral therapy (ART). Recent findings from RV254/SEARCH 010, a longitudinal investigation of acute HIV infection (AHI) and long-term response to ART, identified a combination of immune and behavioral factors (e.g., mental health) that predicted CD4/CD8 T-cell ratio inversion at…

Regulatory T-Cell Manipulation Is Limited by Anti-Antibody Responses in HIV-1 Env-Immunized RMs

Background: CD25+FoxP3+CD4+ regulatory T (Treg) cells help mediate antigen tolerance in immune responses. We aimed to dissect the influence of anti-CD25 monoclonal antibody (mAb) on the germinal center response to immunization. We tested three mAb treatment arms: inhibiting CD25+ Treg cells (Basiliximab), depleting that population (Anti-Tac), and a control (anti-influenza CH65). We immunized a cohort…

Comparison of Anti-HIV ADC and Immunotoxin Shows Clinically Relevant Differences in Cytotoxic Effect

Background: The persistent reservoir of cells carrying a functional provirus is the barrier to HIV eradication. One approach to reservoir depletion is sequential activation of latent virus, followed by purging of HIV-expressing cells. initially it was hoped that once cells were activated, viral cytopathic effect or host immune responses would clear the reservoir, but recent…

Integrated HIV+NCD Care in Community Microfinance Groups: Harambee Cluster Randomized Trial Results

Background: In Sub-Saharan Africa, distance to health facilities, vertical care delivery, increased burden of non-communicable diseases (NCDs), and limited socioeconomic resources are barriers to patients maintaining HIV viral suppression. The Harambee cluster randomized trial tested a differentiated care model delivering HIV+NCD care within microfinance (MF) groups of people living with HIV in western Kenya. Methods:…

Injectable Cabotegravir/Rilpivirine Reach and Effectiveness in a South Side Chicago HIV Clinic

Background: Long-acting injectable (LAI) cabotegravir (CAB) and rilpivirine (RPV) represent a new treatment option for people with HIV (PWH). We sought to understand early reach and effectiveness outcomes in an academic Ryan White clinic serving a primarily Black/African American patient population. Methods: We conducted a retrospective cohort analysis of all PWH referred for LAI CAB/RPV…